Conrado Franco‐Villalobos

发表

Multiple Gene-Environment Interactions on the Angiogenesis Gene-Pathway Impact Rectal Cancer Risk and Survival

J. Potter, M. Slattery, B. Caan, 2017, International journal of environmental research and public health.

Sociodemographic correlates of HIV drug resistance and access to drug resistance testing in British Columbia, Canada

P. Harrigan, J. Shoveller, Z. Brumme, 2017, PloS one.

Correction to: Factors Associated with Mood Disorder Diagnosis Among a Population Based Cohort of Men and Women Living With and Without HIV in British Columbia Between 1998 and 2012

T. Patterson, R. Hogg, J. Montaner, 2019, AIDS and Behavior.

Erratum to: Factors Associated with Mood Disorder Diagnosis Among a Population Based Cohort of Men and Women Living With and Without HIV in British Columbia Between 1998 and 2012

T. Patterson, R. Hogg, J. Montaner, 2017, AIDS and Behavior.

Factors Associated with Mood Disorder Diagnosis Among a Population Based Cohort of Men and Women Living With and Without HIV in British Columbia Between 1998 and 2012

T. Patterson, R. Hogg, J. Montaner, 2017, AIDS and Behavior.

Tobacco Use Among Siblings of Childhood Cancer Survivors: A Report From the Childhood Cancer Survivor Study

C. Recklitis, G. Armstrong, K. Krull, 2016, Pediatric blood & cancer.

Risk of myocardial infarction among people living with HIV: an updated systematic review and meta-analysis

R. Hogg, J. Montaner, E. Mills, 2019, BMJ Open.

Mortality among people living with HIV/AIDS with non-small-cell lung cancer in the modern HAART Era

S. Wiseman, R. Hogg, J. Montaner, 2018, AIDS care.

Changes in mortality rates and causes of death in a population-based cohort of persons living with and without HIV from 1996 to 2012

R. Hogg, J. Montaner, D. Moore, 2017, BMC Infectious Diseases.

Effects of supervised exercise on progression-free survival in lymphoma patients: an exploratory follow-up of the HELP Trial

C. Friedenreich, K. Courneya, T. Reiman, 2015, Cancer Causes & Control.

Cost-Effectiveness of Lisocabtagene Maraleucel Versus Axicabtagene Ciloleucel and Tisagenlecleucel in the Third-Line or Later Treatment Setting for Relapsed or Refractory Large B-cell Lymphoma in the United States

S. Sorensen, I. Proskorovsky, K. Deger, 2023, Advances in therapy.

A Candidate-Pathway Approach to Identify Gene-Environment Interactions: Analyses of Colon Cancer Risk and Survival.

J. Potter, M. Slattery, B. Caan, 2015, Journal of the National Cancer Institute.

Assessing SNP-SNP Interactions among DNA Repair, Modification and Metabolism Related Pathway Genes in Breast Cancer Susceptibility

P. Robson, J. Mackey, C. Cass, 2013, PloS one.

Modeling long-term health and economic implications of new treatment strategies for Parkinson’s disease: an individual patient simulation study

P. Gal, I. Proskorovsky, Yunyang Yang, 2021, Journal of market access & health policy.

Impact of Lenalidomide Treatment on Overall Survival in Patients With Lower-Risk, Transfusion-Dependent Myelodysplastic Syndromes.

P. Fenaux, A. Giagounidis, U. Platzbecker, 2022, Clinical lymphoma, myeloma & leukemia.

Medical resource utilization of abiraterone acetate plus prednisone added to androgen deprivation therapy in metastatic castration‐naive prostate cancer: Results from LATITUDE

S. Sorensen, K. Chi, N. Tran, 2018, Cancer.

Medical resource utilization (MRU) of abiraterone acetate plus prednisone (AAP) added to androgen deprivation therapy (ADT) in metastatic castration-naive prostate cancer: Results from LATITUDE.

S. Sorensen, K. Chi, N. Tran, 2018 .